Evidence map›Paper›PMID 33198113›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Label-Free Visualization and Tracking of Gold Nanoparticles in Vasculature Using Multiphoton Luminescence.

Sean Burkitt, Mana Mehraein, Ramunas K Stanciauskas, Jos Campbell, Scott Fraser, Cristina Zavaleta

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sean BurkittDepartment of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA 90089, USA.ORCID 0000-0002-3896-4089
Mana MehraeinDepartment of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA 90089, USA.
Ramunas K StanciauskasNikon Instruments Inc., 1300 Walt Whitman Road, Melville, NY 11747-3064, USA.ORCID 0000-0002-9827-0716
Jos CampbellDepartment of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA 90089, USA.
Scott FraserDepartment of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA 90089, USA.
Cristina ZavaletaDepartment of Biomedical Engineering, University of Southern California, 1042 Downey Way, Los Angeles, CA 90089, USA.

Funding

A New Strategy for Cancer Detection using Raman Spectroscopy with NanoparticlesK22CA160834 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAVALETA, CRISTINA L. · 2014 to 2016
$582k
NCI NIH HHS K22 CA160834Provost Fellowship n/aTrudi Berwin Fellowship N/a
6 · The paper itself

Abstract

Gold nanoparticles continue to generate interest for use in several biomedical applications. Recently, researchers have been focusing on exploiting their dual diagnostic/therapeutic theranostic capabilities. Before clinical translation can occur, regulatory agencies will require a greater understanding of their biodistribution and safety profiles post administration. Previously, the real-time identification and tracking of gold nanoparticles in free-flowing vasculature had not been possible without extrinsic labels such as fluorophores. Here, we present a label-free imaging approach to examine gold nanoparticle (AuNP) activity within the vasculature by utilizing multiphoton intravital microscopy. This method employs a commercially available multiphoton microscopy system to visualize the intrinsic luminescent signal produced by a multiphoton absorption-induced luminescence effect observed in single gold nanoparticles at frame rates necessary for capturing real-time blood flow. This is the first demonstration of visualizing unlabeled gold nanoparticles in an unperturbed vascular environment with frame rates fast enough to achieve particle tracking. Nanoparticle blood concentration curves were also evaluated by the tracking of gold nanoparticle flow in vasculature and verified against known pre-injection concentrations. Half-lives of these gold nanoparticle injections ranged between 67 and 140 s. This label-free imaging approach could provide important structural and functional information in real time to aid in the development and effective analysis of new metallic nanoparticles for various clinical applications in an unperturbed environment, while providing further insight into their complex uptake and clearance pathways.

Indexed as

gold nanoparticleslabel-free imagingmultiphoton luminescencemultiphoton microscopyreal time imaging

Identifiers

PMID33198113
PMCPMC7696495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.